Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Toni Choueiri MD

Toni K. Choueiri MD

Director, Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute/Brigham and Women’s Hospital; Jerome and Nancy Kohlberg Chair and Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Recent Contributions to PracticeUpdate:

  1. Cabozantinib Plus Nivolumab and Ipilimumab for Renal Cell Carcinoma
  2. Genitourinary Tumor Board: Bladder Cancer
  3. Noninvasive Diagnosis and Monitoring of Bladder Cancer
  4. Practical Selections for First-Line RCC Therapy From PDIGREE: An Alliance-Led Group Study
  5. ESMO: The Promise of HIF2α Inhibition in RCC
  6. Practice Changers in RCC From ESMO 2017
  7. Critical Updates in Urothelial Cancer From ESMO 2017
  8. Promising Investigational Treatment for Bladder Cancer
  9. New Options for Papillary RCC
  10. Current Concepts in Initial and Adjuvant RCC Treatment

Most Read This Week

Recently Updated